国药集团周三宣布已与辉瑞签署COVID-19治疗药物Paxlivid

China Meheco Group Co Ltd (600056.SS) said on Wednesday it signed an agreement with U.S. drugmaker Pfizer Inc (PFE.N) to import and distribute its oral COVID-19 treatment Paxlovid in mainland China, as the country braces for a surge in patients after scaling back its “zero COVID” policy. read more

Pfizer already signed a deal in August for Chinese drugmaker Zhejiang Huahai <600521.SS. to produce Paxlovid in mainland China solely for patients there.

早干嘛去了？